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CCHFvFor some patients infection with Crimean Congo hemorrhagic fever virus (CCHFV) causes a severe disease
characterized by fever, vascular leakage and coagulopathy. Knowledge of CCHF pathogenesis is limited and
today there is no information about the speciﬁc target cells of CCHFV. In this study we analyzed the
permissiveness of human peripheral blood mononuclear cells (PBMCs) including monocyte-derived
dendritic cells (moDCs) to CCHFV infection. Interestingly, we found that moDCs are the most permissive
to CCHFV infection and this infection induced cytokine release from moDCs. Furthermore, supernatants from
infected moDCs were found to activate human endothelial cells.© 2009 Elsevier Inc. All rights reserved.Introduction
Crimean Congo hemorrhagic fever virus (CCHFV) belongs to the
Nairovirus genus in the Bunyaviridae family. It can cause a severe
human disease termed Crimean Congo hemorrhagic fever (CCHF),
with mortality rates ranging from 5 to 70% (Bakir et al., 2005;
Baskerville et al., 1981; Schwarz et al., 1997). CCHFV is endemic in
large parts of the world and considered a threat to public health in
these regions. Second after Dengue, it is the most widespread of the
medically important arthropod-borne viruses. Virus transmission is
known to occur by tick bites from Hyalomma ticks, and by contact
with infected animal blood or tissues. Person to person transmission
can occur via body ﬂuids or through aerosol from patients in advanced
stages of disease (Swanepoel et al., 1987). Handling of the virus
requires specialized biosafety level 4 laboratories (BSL-4), a restriction
resulting in limited knowledge regarding the pathogenesis of CCHF.
Unlike other BSL-4 pathogens, there currently is no animal model
for studying sequential events leading to the hemorrhagic fever
resulting from CCHFV infection; therefore target cell determination
must occur in vitro. In order to address this issue we sought to
determine the target cell populations for CCHFV infection by infecting
human peripheral blood mononuclear cells (PBMCs), B cells, T cells,
NK cells, monocytes and monocyte-derived dendritic cells (moDCs),us Disease Control, Centre for
: +46 8 30 79 57.
ll rights reserved.and analyzing their response to infection by measuring cytokine
release. The biological activity of supernatants derived from moDCs
was further analyzed by exposing human umbilical vein endothelial
cells (HUVECs) to these supernatants and quantifying intercellular
adhesion 1 (ICAM-1) mRNA expression.
Results
Monocyte-derived dendritic cells are productively infected by CCHFV
PBMCs were puriﬁed from buffy coats and subsequently sorted by
ﬂuorescence activated cell sorting (FACS) into cell subsets consisting
of B cells, T cells, NK cell and monocytes. MoDCs were also generated
following 6-day culture with IL-4 and GM-CSF. The purity of all the
sorted cell populations was consistently N95% as shown in Fig. 1A. The
sorted cells were infected with CCHFV at a MOI of 10 and RNA
extracted 24 and 48 hs post infection (hpi) to quantify the CCHFV RNA
levels in the infected versus uninfected cells. In contrast to other cells,
CCHFV RNA was found in moDCs at 24 hpi and more pronounced
levels were measured at 48 hpi (Fig. 1B). Further veriﬁcation of moDC
susceptibility to CCHFV infection was performed by intracellular
immunoﬂuorescence (IF) staining for CCHFV NP in moDCs at 48 hpi.
As shown in Fig. 1C, CCHFV NP was observed in the cytoplasm of
moDCs. Intracellular NP was not observed with IF in the other cell
types nor could CCHFV NP be detected with Western blotting (data
not shown).
To determine whether CCHFV induced a productive infection in
target cells, the supernatants of all cell types were harvested at 48 hpi
Fig. 1.moDCs are infected by CCHFV. (A) Total human PBMCs were stained for CD14, CD19, CD56, and CD3 and sorted using ﬂow cytometry into four cell subsets consisting of B cells
(CD19+), T cells (CD3+CD56−), NK cells (CD3−CD56+) and monocytes (CD14+). The purity of each of the sorted cell populationwas evaluated after sorting and was consistently
N95%. (B) Total PBMCs, B cells, T cells, NK cells, monocytes and moDCs were infected with CCHFV at MOI 10. At 24 and 48 hpi cells were harvested for determination of CCHFV RNA
levels. Results are shown as fold increase of mock infected cells within each time point. Only moDCs show an increase of RNA levels, whereas RNA levels in total PBMCs and all other
PBMC subsets aremuch lower. (C)Mock infected and infectedmoDCswereﬁxed and stained for CCHFVNP 48 hpi. Infected cells show the characteristic cytoplasmic localization of NP.
158 Rapid Communicationand progeny viruses were quantiﬁed. Consistent with the data
described above, and as depicted in Fig. 2, we found that the only
cell types, which could be productively infected were moDCs.
Cytokine response of moDCs to CCHFV infection
Earlier studies have shown that elevated IL-6 and TNF-α levels are
detected in sera of CCHFV infected persons and correlate positively to
severity of disease (Ergonul et al., 2006; Papa et al., 2006). Given that
CCHFV can infect moDCs, we were interested in determining whetherFig. 2.moDCs are productively infected by CCHFV. Supernatants from 48 hpi infected or
mock infected PMBCs and subsets were titrated for progeny virions. Progeny viruses
were only detectable in moDCs.the infection resulted in cytokine production. To address this question,
we measured the secretion of TNF-α, IL-6, IL-10, IL-8, IL-19 and IL-1β
following infection by CCHFV of moDCs derived from four naïve
donors (termed A, B, C and D). Cell-free supernatants were collected at
48 hpi and assayed by ELISA for the previously mentioned cytokines.
As shown in Fig. 3A consistently higher levels of TNF-α, IL-6 and IL-10
were measured in supernatants from infected moDCs compared to
uninfected cells. However, there was no difference between infected
and uninfected cells with regards to IL-8, IL-19 and IL-1β release
(Fig. 3A and data not shown). LPS (1 μg/ml) was included as a positive
control for all cytokines (data not shown). Relative Q-PCR analysis for
CCHFV infection of moDCs from the same donors (Fig. 3B) veriﬁes
infection of moDCs.
Supernatants from infected moDCs activate endothelial cells
The role of the endothelium in viral hemorrhagic fevers (VHFs) has
not been clariﬁed, but it can be targeted in two ways. Either the
activation and dysfunction is caused directly by virus infection and
replication or the endothelium is targeted indirectly by virus-
mediated host-derived soluble factors (Schnittler and Feldmann,
2003). Intercellular adhesion molecule 1 (ICAM-1) expression is
increased upon endothelial activation, and it can therefore be used as
a marker of activation (Hubbard and Rothlein, 2000). To address the
role of secreted pro-inﬂammatory factors from infected moDCs in
endothelial activation, we exposed conﬂuent HUVECs to cell culture
medium, LPS, or supernatants from uninfected and infected moDCs
collected at 48 hpi. RNAwas extracted fromHUVECs 6 h after exposure
and ICAM-1 mRNA relatively quantiﬁed with RT-PCR. As illustrated in
Fig. 4A, endothelial cells respond to LPS treatment by increasing
Fig. 3. Increased release of IL-6, IL-10 and TNF-α from infected moDCs. (A) Supernatants frommock infected and infected moDCs at 48 hpi were analyzed for TNF-α, IL-6, IL-10, IL-8
and IL-19 by ELISA. Infected moDCs seem to release higher levels of IL-6, IL-10 and TNF-α compared to uninfected cells, however no clear differences were observed with regards to
IL-8 and IL-19 release. (B) CCHFV NP RNA levels for all four donors at 48 hpi are shown verifying infection.
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Fig. 4. Supernatants from infected moDCs activate endothelial cells. HUVEC cell layers
were exposed for 6 h to cell culture medium (negative control), LPS 100 μg/ml (positive
control) and to supernatants from mock infected and infected moDCs. Only moDC
supernatants and LPS treatment activate endothelial cells as measured by ICAM-1
mRNA (A) and protein (B) up-regulation.
160 Rapid CommunicationmRNA levels of ICAM-1 by more than 30-fold compared to the base
line ICAM-1 mRNA levels in the negative control. Supernatants from
CCHFV infected moDCs also activate endothelial cells as shown by a
similar 30-fold increase of ICAM-1 mRNA. Exposure of endothelial
cells to CCHFV alone does not cause ICAM-1 mRNA levels to increase
after 6 hpi (data not shown). These results are veriﬁed by Western
blotting (Fig. 4B).
Discussion
CCHF pathogenesis is poorly studied due to several reasons, (i) the
virus is classiﬁed as a BSL-4 pathogen, (ii) currently no in vivo model
exists and (iii) CCHF outbreaks are sporadic and very few of the
endemic countries have the required safety facilities for working with
infectious material.
The only published information regarding human target cells
originated from post mortem studies of CCHF patients showing
consistent infection of hepatic endothelial cells and macrophages
(Burt et al., 1997). However, that study represents the end-point of a
fatal infection and the initial cellular targets of CCHFV remain
undeﬁned. This is the ﬁrst in vitro study to our knowledge, which
focuses on characterizing the susceptibility of human blood cells to
CCHFV infection and identiﬁes immature moDCs as permissive to
CCHFV infection and replication. This is in line with previous studies
where several members of viral hemorrhagic fevers can infect
moDCs (Bosio et al., 2003; Ho et al., 2001; Mahanty et al., 2003;
Raftery et al., 2002).
In addition, we ﬁnd an increased release of the cytokines IL-6,
TNF-α and IL-10 from infected moDCs compared to uninfected cells.
Two separate patient studies in Albania and Turkey indicate that IL-6
and TNF-α are the cytokines mostly induced during CCHF infection.
In both studies, the levels of TNF-α correlated with disease severity
(Ergonul et al., 2006; Papa et al., 2006). The role of IL-6 is moreunclear since the Turkish study found a correlation with IL-6 levels
and fatality (Ergonul et al., 2006), but the Albanian study found IL-6
to be elevated both in mild and severe forms of the disease casting
some uncertainty as to the prognostic value of this cytokine (Papa et
al., 2006). The role of IL-10 in CCHF disease severity is also unclear.
In the Albanian study, there were high levels of IL-10 in the only
patient that succumbed (Papa et al., 2002) however in the Turkish
study IL-10 correlated negatively with disseminated intravascular
coagulopathy (Ergonul et al., 2006). We also tested other molecules
that could potentially play a role in pathogenesis of viral hemor-
rhagic fever viruses (IL-1β and IL-8) or attributed a role in tissue
injury in sepsis (IL-19) (Baize et al., 2002; Hsing et al., 2008;
Talavera et al., 2004). Here, in our in vitro study, we could not
demonstrate any differences between CCHFV infected and unin-
fected moDC release of these molecules.
Other studies of hemorrhagic fever viruses show contradictory
responses of moDCs and various patterns in cytokine responses to
infection (Baize et al., 2002, 2009; Bosio et al., 2003; Bozza et al., 2008;
Ho et al., 2001; Mahanty et al., 2003; Raftery et al., 2002; Scott and
Aronson, 2008). The diverging responses to infection could possibly
be one of the reasons for explaining the difference in molecular
pathogenesis for VHFs. Our studies suggest that dendritic cells could
contribute to the elevated cytokine response observed in CCHF
patients; however there is need of an animal model to pinpoint the
role of dendritic cells in CCHF pathogenesis.
Furthermore, we show that supernatants from infected moDCs
activate endothelial cells by up-regulating ICAM-1 expression. The
ICAM-1 up-regulation is not dependent on viral infection as infected
endothelial cells do not respond after 6 hpi, indicating it is virally
induced soluble mediators from moDCs that activates endothelial
cells. One of the most obvious symptoms in VHFs is bleeding
indicating endothelial dysfunction. This dysfunction could be caused
by direct viral infection or indirect by activation of immunological
and inﬂammatory pathways (Schnittler and Feldmann, 2003). It is
now clear that Ebola viruses do not directly cause endothelial
damage, and that the vascular leakage is likely a result of a de-
regulated immune response (Baize et al., 2002; Geisbert et al., 2003).
What occurs in CCHF patients is not clear; however our previous
study investigating the effect of in vitro infection on tight junction
integrity supports the notion of indirect effect (Connolly-Andersen
et al., 2007; Weber and Mirazimi, 2008). Likewise the expression of
ICAM-I of endothelial cells upon exposure to moDC supernatants in
vitro further supports an indirect effect, but more extensive studies
are needed to clarify the interplay between the immune system and
the endothelium to understand CCHF pathogenesis.
Materials and methods
Human peripheral blood cell isolation
Peripheral blood mononuclear cells (PBMCs) were obtained from
healthy blood donors by collection of buffy coats provided by the
blood bank at the Karolinska Hospital and following Ficoll-Paque (GE
Healthcare) density gradient centrifugation. Following separation,
cells were stained for CD14, CD56, CD3 and CD19 (all from BD
Pharmingen). Monocytes, B cells, T cells and NK cells were isolated by
sorting CD14+, CD19+, CD3+CD56−, CD56+CD3− cells, respec-
tively, on a FACS Aria ﬂow cytometer (BD Immunohistochemistry
Systems). Following puriﬁcation, samples were acquired on a FACS
Aria and analyzed with FlowJo software.
In vitro differentiation of monocyte-derived dendritic cells
PBMCs were enriched for monocytes following plastic adhesion
during 2 h at 37 °C. To obtain immature DCs, monocytes were further
cultured for 6 dayswith RPMI 1640medium containing 10% FCS, 2mM
161Rapid CommunicationL-glutamin, 100 U/ml penicillin, 100 M streptomycin, 2% HEPES (all
from Invitrogen Life Technologies) with 200 ng/ml GM-CSF (Pepro-
tech) and 75 ng/ml r-IL4 (R and D systems).
Cell infection and stimulation
Cells were infected with CCHFV strain Ibar 10200 at an MOI of 10
or mock infected with cell culture medium and incubated at 37 °C in
a 5% CO2 humidiﬁed atmosphere for 24 or 48 hpi. Following infection
cells were centrifuged and supernatants were saved for further
analysis. Cell pellets were re-suspended in medium and cells were
treated to prepare for RNA isolation or IF staining to determine
CCHFV infectivity.
Human umbilical vein endothelial cells (HUVECs) (Lonza, Walk-
ersville, MD) were grown according to the manufacturer's instruc-
tions. Conﬂuent HUVECs were exposed to supernatants from moDCs
or treated with cell culture medium or 100 μg/ml LPS (Wollin et al.,
1987). After 6 hour stimulation, cells were harvested and subjected
to ICAM-1 determination by Q-PCR. All handling of the virus
occurred in a BSL-4 laboratory at the Swedish Institute for Infectious
Disease Control.
RNA isolation
Total RNA was isolated by chloroform extraction from Trizol
treated cells. RNA extraction from the aqueous phase was performed
using the Qiagen Mini Viral RNA kit according to the manufacturer's
instructions and reverse transcribedwith random primers yield cDNA.
Relative quantitative PCR
Quantiﬁcation of ICAM-1, GAPDH and CCHFV NP cDNA was
performed on the Applied Biosystems 7900 HT sequence detection
system. Speciﬁc primerswere designed for CCHFVNP: Forward primer
5′-GCCATGATGTATTTGCCTTTGA-3′, reverse primer 5′-CCAGTGAGC-
CATGAGCATGT-3′; ICAM-1: forward primer 5′-TGGCCCTCCATAGA-
CATGTGT-3′, reverse primer 5′-TGGCATCCGTCAGGAAGTG-3′ and
GAPDH: forward primer 5′-CAGCATCGCCCCACTTG-3′, reverse primer
5′-GAAATCCCATCACCATCTTCCA-3′. The expression of GAPDH served
as an internal standard. The following formulas were applied for
calculating results: Ct=gene Ct−GAPDH Ct where Ct indicates the
cycle threshold of GAPDH and gene of interest. Results were calibrated
against a negative control and further analysed by the 2−Δct method.
Western blotting
Western blotting was performed as previously described
(Connolly-Andersen et al., 2007). Brieﬂy described, infected cells
were lysed in lysis buffer and separation of polypeptides occurred in
an SDS-PAGE gel. Electrophoresis was carried out at a constant current
of 200 volts. Transfer of proteins occurred to a nitrocellulose
membrane followed by blocking of the membrane in 5% milk in 0.1%
Tween (PBS-T). Following blocking, the membranes were incubated
with rabbit anti-Calnexin or rabbit anti-ICAM-1. After washing in PBS-
T, the membranes were developed with Amersham ECL Plus Western
blotting detection reagents (GE Healthcare, Buckinghamshire, UK)
according to the manufacturer's protocol.
Immunoﬂuorescence assay
Aliquots of moDCs were spun in the Shandon Cytospin 4 centrifuge
(Thermo) on to slides. Slides were ﬁxed with ice-cold 80% acetone.
The cells were incubated with a primary rabbit polyclonal anti-CCHFV
NP (Andersson et al., 2004) followed by anti-rabbit FITC-conjugated
antibodies. DAPI (Sigma, St. Louis, MO) was added to stain cell nuclei.
Slides were analysed by immunoﬂuorescence microscopy. Pictureswere obtained with a Hamamatsu digital camera (Wasabi 1.4
Hamamatsu; Photonics, GmbH, Germany).Cytokine quantiﬁcation
Supernatants from treated, infected or untreated cells were
collected and assayed for concentrations of IL-1β, IL-6, IL-10, TNF-α
(Mabtech, Sweden), IL-8 and IL-19 (R and D Systems, United
Kingdom) by ELISA according to the manufacturer's protocol.Virus titration assay
Progeny virions were determined as previously described
(Connolly-Andersen et al., 2007). Brieﬂy, Vero E6 cells were
grown in 96 well plates and infected with serially diluted super-
natants from infected or non-infected cells. The cells were ﬁxed
with 80% acetone and staining of CCHFV NP was performed as
described above. Fluorescing foci were counted in a microscope,
enabling calculation of progeny virus titers.Acknowledgments
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